Today: 22 July 2026
Browse Category

NASDAQ:NVDA 13 January 2026 - 15 January 2026

AI chip stocks rally: Nvidia and AMD jump on TSMC outlook as Trump tariff clouds China trade

AI chip stocks rally: Nvidia and AMD jump on TSMC outlook as Trump tariff clouds China trade

Shares of Nvidia and Advanced Micro Devices surged Thursday, fueling gains across AI-focused chip stocks following Taiwan Semiconductor Manufacturing Co’s strong profit report and boosted investment outlook. By 10:15 a.m. ET, Nvidia had climbed 2.8%, while AMD jumped 5.5%. U.S.-listed TSMC shares rose 6.3%, ASML gained 6.2%, and Broadcom added around 2%, though Qualcomm dipped 0.8%.
Nvidia stock today: NVDA rises in premarket as China drafts rules for H200 chip buys

Nvidia stock today: NVDA rises in premarket as China drafts rules for H200 chip buys

Nvidia Corp shares climbed 1.8% in Thursday premarket trading to $186.40, rebounding after a 1.4% drop on Wednesday, according to MarketWatch. The move followed a Nikkei Asia report saying China is drafting rules to limit how many advanced AI chips local companies can import from suppliers like Nvidia. Reuters, unable to confirm the Nikkei report, added that Beijing has instructed some firms to pause purchases of Nvidia’s H200 chips, with customs reportedly blocking shipments, sources told Reuters.
15 January 2026
Nvidia stock slips as China blocks H200 chips and Washington adds new tariff risk

Nvidia stock slips as China blocks H200 chips and Washington adds new tariff risk

Nvidia shares dropped early Thursday in U.S. trading after a Reuters report revealed Chinese customs agents were instructed to block the company’s H200 AI chips from entering the country. The stock slipped 1.5% to $183.14, down from $185.85 at Wednesday’s close. The report also noted that some Chinese tech firms were advised not to buy the chips unless absolutely necessary, though it remains unclear if this is a formal ban or a temporary restriction.
15 January 2026
Trump’s New AI Chip Tariff Jolts Nvidia Stock After Hours as AMD Holds Up

Trump’s New AI Chip Tariff Jolts Nvidia Stock After Hours as AMD Holds Up

Nvidia shares dipped 1.5% to $183.14 in after-hours trading Wednesday following President Donald Trump’s announcement of a 25% tariff on certain advanced computing chips, including Nvidia’s H200 AI processor. Meanwhile, AMD, whose MI325X chip was also named in the White House fact sheet, gained 1.2%, closing at $223.60.
Nvidia stock dips on China H200 roadblock as U.S. export rules shift — what NVDA traders watch next

Nvidia stock dips on China H200 roadblock as U.S. export rules shift — what NVDA traders watch next

Nvidia stock slipped 1.6% to $182.79 late Wednesday after Reuters reported that Chinese customs told agents the company’s H200 AI chips can’t enter the country. Officials also cautioned local tech firms against buying them unless absolutely necessary. It’s not clear if this amounts to an official ban. Rhodium Group strategist Reva Goujon suggested Beijing might be “pushing to see what bigger concessions they can get” ahead of President Donald Trump’s April visit to meet Xi Jinping.
14 January 2026
Nvidia stock falls as China blocks H200 AI chips despite U.S. export approval

Nvidia stock falls as China blocks H200 AI chips despite U.S. export approval

Nvidia shares fell 2.2% to $181.77 in afternoon trading on Wednesday after Reuters reported Chinese customs officials were told the company’s H200 artificial intelligence chips are not permitted to enter China. Chinese officials also summoned domestic technology companies and warned them not to buy the chips unless necessary, while exemptions for universities and research work were being discussed, the report said. Rhodium Group strategist Reva Goujon said Beijing was “pushing” for bigger concessions ahead of U.S. President Donald Trump’s planned April visit.
Nvidia stock drops on China H200 curb — the next date AI investors are watching

Nvidia stock drops on China H200 curb — the next date AI investors are watching

Nvidia shares dipped early Wednesday after Reuters reported that Chinese customs officials told agents this week the company’s H200 AI chips cannot enter China. The report added that local tech firms were advised to avoid purchasing the chips unless absolutely necessary—a move one insider called “basically a ban for now.” Rhodium Group strategist Reva Goujon suggested Beijing might be “pushing to see what bigger concessions they can get” ahead of President Donald Trump’s planned April trip to Beijing.
Nvidia stock (NVDA) steadies as China blocks H200 chip imports, clouding U.S. export green light

Nvidia stock (NVDA) steadies as China blocks H200 chip imports, clouding U.S. export green light

Nvidia shares ticked up 0.5% to $185.81 in early Wednesday trading after Reuters reported that Chinese customs officials instructed agents to block imports of the company’s H200 AI chips. This move complicates any potential restart of sales in China. The report added that Chinese regulators have warned local tech firms against buying the chips unless absolutely “necessary,” injecting fresh uncertainty into a market that has closely watched China access as a key driver for Nvidia’s stock.
14 January 2026
Nvidia stock braces for a China shock as customs blocks H200 AI chips despite U.S. export nod

Nvidia stock braces for a China shock as customs blocks H200 AI chips despite U.S. export nod

Nvidia shares inched up about 0.5% to $185.81 in U.S. premarket trading Wednesday, despite reports that Chinese customs officials told agents the company’s H200 AI chips aren’t allowed into China. Sources briefed on the situation said Beijing also warned local tech firms against buying the chips unless absolutely necessary. Rhodium Group strategist Reva Goujon suggested China might be “pushing to see what bigger concessions they can get” ahead of President Donald Trump’s planned April visit.
14 January 2026
Thermo Fisher stock falls as CEO flags new U.S. reshoring contracts, Nvidia tie-up in focus

Thermo Fisher stock falls as CEO flags new U.S. reshoring contracts, Nvidia tie-up in focus

Thermo Fisher Scientific’s pharmaceutical services unit has secured contracts to assist clients shifting drug manufacturing from Europe or Asia back to the U.S., CEO Marc Casper revealed Tuesday. Shares slipped 1.4% to close at $607.08. Casper highlighted a strong push toward reshoring production and operations to the U.S., calling it a boost for 2027 and 2028 as a proposed 100% tariff on imported medicines looms.
1 41 42 43 44 45 96
Go toTop